{
    "title": "AstraZeneca snaps up US drug firm for \u00a31.8bn in search for hyperkalaemia treatment",
    "url": "https://www.dailymail.co.uk/money/markets/article-3306682/AstraZeneca-snaps-drug-firm-1-8bn-search-hyperkalaemia-treatment.html",
    "date": "2015-11-06",
    "keywords": [
        "drug",
        "astrazeneca",
        "disease",
        "heart",
        "treatment",
        "cancer",
        "zs",
        "deal",
        "hyperkalaemia",
        "kidney",
        "approval",
        "share",
        "year",
        "pharma",
        "acquisition",
        "boss",
        "soriot",
        "condition",
        "risk",
        "market",
        "group",
        "giant",
        "dollar",
        "cash",
        "firm",
        "access",
        "medicine",
        "food",
        "administration",
        "failure",
        "prevalence",
        "cure",
        "failurethis",
        "focus",
        "cardiovascular",
        "bestinclass",
        "portfolio",
        "per",
        "part",
        "shot",
        "arm",
        "drugmaker",
        "jump",
        "blood",
        "article",
        "yesterday",
        "revenue",
        "guidance",
        "brilinta",
        "mood",
        "pharmasoriot",
        "respiratory",
        "lupus",
        "company",
        "raft",
        "development",
        "durvalumab",
        "lung",
        "end",
        "yearnevertheless",
        "pressure",
        "growth",
        "loss",
        "exclusivity",
        "bestselling",
        "crestor",
        "cholesterol",
        "statin",
        "tenth",
        "expiry",
        "nexium",
        "heartburn",
        "drugthe",
        "nearing",
        "addition",
        "zs9",
        "product",
        "lineup",
        "takeover",
        "bid",
        "pfizer",
        "week",
        "chip",
        "glaxosmithkline",
        "quarter",
        "demand",
        "hiv",
        "flu"
    ],
    "category": [
        "money",
        "markets"
    ]
}